Lorenc Zbigniew Paul
Known title: DirectorCIK: 0002127734
Associated companies
Transaction History
| CNXU | ▲ Buy | Grant | 11,175 | $0 | 5/14/2026 | View on chart |
| CNXU | ▲ Buy | Grant | 11,175 | $0 | 5/14/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
CNXU Provides Update on FDA 510(k) Program for Wound Care Device
Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.
CNXU Provides Update on FDA 510(k) Program for Wound Care Device. Conexeu Sciences released an update describing its regulatory and manufacturing program that supports a planned FDA 510(k) premarket notification for a ten‑minute tissue, lead wound‑care device candidate. The announcement signals progress toward filing the notification and may affect the timeline for potential market entry. The stock is currently near a support level of $9.62 and has an RSI of 31.4, suggesting limited momentum.